Scleroderma (pulmonary manifestations)

Pulmonary manifestations of scleroderma are demonstrated histologically in 90% of patients with scleroderma. It is a leading cause of mortality and at autopsy. The lung is reportedly involved in close to 100% of cases. However, only 25% of patients will present with respiratory symptoms or demonstrate abnormalities on CT 4

For a discussion of scleroderma in general, refer to parent article: scleroderma.

In patients who are symptomatic due to pulmonary involvement, respiratory function tests typically demonstrate a restriction pattern, consisting of 4:

  • diminished lung volumes
  • preserved flow rates
  • low diffusion capacity

The pathogenesis of pulmonary involvement relates to separate mechanisms:

The two pathologies may co-exist. The remainder of the article discusses the former. Please refer to aspiration pneumonitis for discussion of that entity. 

Chest radiographs are insensitive to early changes, and may appear normal despite respiratory function test abnormalities. Eventually, changes of pulmonary fibrosis become evident. Additional features include 4:

  • dilated oesophagus
  • eggshell calcification of mediastinal nodes
  • pleural effusions are uncommon
  • enlargement of cardiac silhouette and pulmonary arteries due to scleroderma induced pulmonary vascular disease may also be evident. 

On HRCT, scleroderma may appear in either a usual interstitial pneumonitis (UIP) or non-specific interstitial pneumonitis (NSIP) pattern (the latter is considered more common 5). Interstitial lung changes in scleroderma are less extensive and less coarse than those with idiopathic pulmonary fibrosis (IPF) 3 with most patients only show a limited portion of lung involvement (less than 10% in half of cases) 1.

  • early stages may show ground glass changes
  • later stages may show honeycombing and evidence of lung volume loss
  • lung bases and sub-pleural regions typically involved 4
  • cysts may be present measuring 1-5cm in diameter 4
  • pleural effusions are usually not a feature
  • CT may also show features of pulmonary hypertension
  • bronchiectasis:
    • tends to be cylindrical in general
    • may be present in around 60% of patient according to one study 8

A dilated oesophagus is not an uncommon finding. 

Pulmonary involvement is incurable but some compounds may improve or halt progression. These include cyclophosphamide, glucocorticoids or N-acetylcysteine, although the data is inconclusive 5

Complications include:

The cause of death is often from aspiration pneumonia.

On HRCT, the differential is essentially that of usual interstitial pneumonia and lower zone pulmonary fibrosis.

A helpful clue to the diagnosis on CT is the presence of a dilated oesophagus.
Pleural effusions are distinctly uncommon in scleroderma, and would favour the diagnosis or either rheumatoid lung or SLE 4.

Share article

Article information

rID: 8608
Systems: Chest, Oncology
Synonyms or Alternate Spellings:
  • Scleroderma (pulmonary features)
  • Scleroderma (lung features)
  • Scleroderma (lung manifestations)
  • Lung manifestations of scleroderma
  • Pulmonary manifestations of systemic sclerosis
  • Lung manifestations of systemic sclerosis
  • Pulmonary manifestations of scleroderma

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Case 1
    Drag here to reorder.
  • Drag
    Case 2
    Drag here to reorder.
  • Drag
    CECT LUNG WINDOW ...
    Case 3
    Drag here to reorder.
  • Drag
    Case 4: with a NSIP pattern
    Drag here to reorder.
  • Drag
    Case 5: with an NSIP pattern
    Drag here to reorder.
  • Drag
    Case 6: with a UIP pattern
    Drag here to reorder.
  • Drag
    Case 7: with a UIP pattern
    Drag here to reorder.
  • Drag
    Case 8: probable NSIP pattern
    Drag here to reorder.
  • Updating… Please wait.
    Loadinganimation

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.